F. D'Amico

发表

Thiopurines and non-melanoma skin cancer: partners in crime in inflammatory bowel diseases.

L. Peyrin-Biroulet, S. Danese, C. Correale, 2020, British medical bulletin.

Long-term safety of approved biologics for ulcerative colitis

S. Bonovas, L. Peyrin-Biroulet, S. Danese, 2020, Expert opinion on drug safety.

Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question

G. Fiorino, S. Danese, M. Allocca, 2022, Journal of clinical medicine.

Phase 1, 2 and 3 trials in inflammatory bowel diseases: a practical guide for the non-specialist.

L. Peyrin-Biroulet, S. Danese, C. Baumann, 2020, Journal of Crohn's & colitis.

Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting

S. Ng, C. Lees, C. O'Morain, 2020, Gastroenterology.

Lactobacillus paracasei CNCM I 1572: A Promising Candidate for Management of Colonic Diverticular Disease

A. Tursi, S. Danese, F. D'Amico, 2022, Journal of Clinical Medicine.

Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2022, Drug design, development and therapy.

Role of Cross-Sectional Imaging in Pediatric Inflammatory Bowel Disease

L. Peyrin-Biroulet, S. Danese, V. Laurent, 2021, Digestive Diseases and Sciences.

Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing.

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2019, Immunotherapy.

Setting up a Virtual Calprotectin Clinic in Inflammatory Bowel Diseases: Literature Review and Nancy Experience

L. Peyrin-Biroulet, S. Danese, I. Aimone-Gastin, 2020, Journal of clinical medicine.

Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Clinical Gastroenterology and Hepatology.

Which MRI Score and Technique Should Be Used for Assessing Crohn’s Disease Activity?

L. Peyrin-Biroulet, S. Danese, V. Laurent, 2020, Journal of clinical medicine.

Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review

L. Peyrin-Biroulet, S. Danese, K. Paridaens, 2022, United European gastroenterology journal.

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.

A. Griffiths, W. Bemelman, D. Rubin, 2020, Gastroenterology.

JAK inhibitors in crohn’s disease: ready to go?

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2022, Expert opinion on investigational drugs.

Motivation to pursue anti-TNFα treatment in patients with Crohn's disease - the SPACE motivation study.

L. Peyrin-Biroulet, X. Hébuterne, Y. Bouhnik, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study

S. Bonovas, L. Peyrin-Biroulet, G. Fiorino, 2022, United European gastroenterology journal.

Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art

G. Fiorino, S. Danese, M. Allocca, 2022, Journal of clinical medicine.

Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn’s disease

S. Bonovas, L. Peyrin-Biroulet, G. Fiorino, 2021, Alimentary pharmacology & therapeutics.

Histological disease activity measured by the Nancy index is associated with long-term outcomes in patients with ulcerative colitis.

L. Peyrin-Biroulet, S. Danese, C. Baumann, 2021, Journal of Crohn's & colitis.

Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2020, Journal of clinical medicine.

Evolution of infliximab biosimilar in inflammatory bowel disease: from intravenous to subcutaneous CT-P13

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Expert Opinion on Biological Therapy.

Early Intervention in Ulcerative Colitis: Ready for Prime Time?

L. Peyrin-Biroulet, S. Danese, V. Solitano, 2020, Journal of clinical medicine.

JAK inhibitors: Novel developments in management of ulcerative colitis.

G. Fiorino, S. Danese, F. D'Amico, 2018, Best practice & research. Clinical gastroenterology.

Landscape of new drugs and targets in inflammatory bowel disease

L. Peyrin-Biroulet, S. Danese, P. Netter, 2022, United European gastroenterology journal.

Abdominal Pain in Inflammatory Bowel Diseases: A Clinical Challenge

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2022, Journal of clinical medicine.

Herpes zoster and vaccination strategies in inflammatory bowel diseases: a practical guide.

S. Ng, L. Peyrin-Biroulet, S. Danese, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Filgotinib for moderately to severely active ulcerative colitis

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2022, Expert review of gastroenterology & hepatology.

Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Journal of clinical medicine.

Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials

G. Fiorino, S. Danese, M. Allocca, 2018, Expert Opinion on Investigational Drugs.

Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?

L. Peyrin-Biroulet, S. Danese, G. Roda, 2019, Current pharmaceutical design.

Cross-Sectional Imaging Instead of Colonoscopy in Inflammatory Bowel Diseases: Lights and Shadows

G. Fiorino, S. Danese, M. Allocca, 2022, Journal of clinical medicine.

NOD2/CARD15 polymorphisms (P268S, IVS8+158, G908R, L1007fs, R702W) among Kuwaiti patients with Crohn's disease: A case-control study

L. Peyrin-Biroulet, N. Ndiaye, F. D'Amico, 2021, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

Upadacitinib for Crohn's disease and ulcerative colitis treatment: hitting the selective JAKpot.

S. Danese, F. D'Amico, T. Parigi, 2020, Gastroenterology.

Ulcerative colitis: Impact of early disease clearance on long‐term outcomes ‐ A multicenter cohort study

S. Bonovas, L. Peyrin-Biroulet, G. Fiorino, 2022, United European gastroenterology journal.

Paradoxical gastrointestinal effects of interleukin-17 blockers

D. Loeuille, L. Peyrin-Biroulet, P. Netter, 2020, Annals of the Rheumatic Diseases.

Patient’s profiling for therapeutic management of inflammatory bowel disease: a tailored approach

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2020, Expert review of gastroenterology & hepatology.

Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

J. Gisbert, U. Kopylov, S. Sebastian, 2020, Journal of clinical medicine.

Bowel Ultrasound in Inflammatory Bowel Disease: How Far in the Grayscale?

S. Danese, M. Allocca, F. D'Amico, 2021, Life.

International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases

E. Louis, D. Rubin, L. Peyrin-Biroulet, 2021, United European gastroenterology journal.

Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2019, Therapeutic advances in gastroenterology.

Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey

L. Peyrin-Biroulet, S. Danese, J. Rahier, 2020, The Lancet Gastroenterology & Hepatology.

Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management

Daniel C. Baumgart, L. Peyrin-Biroulet, S. Danese, 2020, Clinical Gastroenterology and Hepatology.

Early Biological Therapy in Operated Crohn’s Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2022, Inflammatory bowel diseases.

New drugs in the pipeline for the treatment of inflammatory bowel diseases: what is coming?

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2020, Current opinion in pharmacology.

TNF inhibitors and risk of malignancy in patients with inflammatory bowel diseases: a systematic review.

S. Bonovas, L. Peyrin-Biroulet, S. Danese, 2020, Journal of Crohn's & colitis.

Efficacy of anti-TNFα drugs in patients with stricturing Crohn’s disease

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Expert review of gastroenterology & hepatology.

Clinical Features of SARS-CoV-2 Infection in Italian Long-Term Care Facilities: GeroCovid LTCFs Observational Study

V. Ippolito, S. Volpato, M. Noale, 2021, Journal of the American Medical Directors Association.

Positioning Filgotinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis

L. Peyrin-Biroulet, S. Danese, F. Magro, 2021, Journal of Crohn's & colitis.

Endpoints for perianal Crohn's disease trials: past, present, and future.

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2021, Journal of Crohn's & colitis.

Assessment of extraintestinal manifestations in inflammatory bowel diseases: A systematic review and a proposed guide for clinical trials

A. Costanzo, D. Loeuille, L. Peyrin-Biroulet, 2020, United European gastroenterology journal.

Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review

S. Wexner, L. Peyrin-Biroulet, S. Danese, 2020, United European gastroenterology journal.

Review article: faecal calprotectin and histologic remission in ulcerative colitis

S. Bonovas, L. Peyrin-Biroulet, S. Danese, 2020, Alimentary pharmacology & therapeutics.

A practical guide for faecal calprotectin measurement: myths and realities.

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Journal of Crohn's & colitis.

Positioning Tofacitinib in the Treatment Algorithm of Moderate to Severe Ulcerative Colitis.

S. Bonovas, L. Peyrin-Biroulet, S. Danese, 2018, Inflammatory bowel diseases.

Unmet Needs in IBD: the Case of Fatigue

D. Laukens, S. Danese, P. Hindryckx, 2018, Clinical Reviews in Allergy & Immunology.

Endoscopic Vacuum Therapy (EVT) versus Self-Expandable Metal Stent (SEMS) for Anastomotic Leaks after Upper Gastrointestinal Surgery: Systematic Review and Meta-Analysis

W. Bemelman, G. Fiorino, S. Danese, 2023, Life.

Endoscopic vacuum therapy for post-esophagectomy anastomotic dehiscence as rescue treatment: a single center case series

S. Danese, F. Azzolini, D. Esposito, 2022, Esophagus.

Efficacy of a New Nutraceutical Formulation in Patients with Symptomatic Uncomplicated Diverticular Disease (SUDD): a Prospective Observational Study.

A. Tursi, S. Danese, F. D'Amico, 2020, Journal of gastrointestinal and liver diseases : JGLD.

SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2020, Nature Reviews Gastroenterology & Hepatology.

Predictors for short bowel syndrome in Crohn's disease.

D. Quilliot, L. Peyrin-Biroulet, S. Danese, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Transmural healing as a therapeutic goal in Crohn's disease: a systematic review.

L. Peyrin-Biroulet, S. Danese, V. Laurent, 2021, The lancet. Gastroenterology & hepatology.

Ustekinumab for extra-intestinal manifestations of inflammatory bowel disease: a systematic literature review.

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Journal of Crohn's & colitis.

Knowledge of 5-aminosalicylic acid nephrotoxicity and adherence to kidney function monitoring of patients with inflammatory bowel disease

F. Guillemin, L. Peyrin-Biroulet, S. Danese, 2020, European journal of gastroenterology & hepatology.

Kidney function monitoring to prevent 5-aminosalicylic acid nephrotoxicity: What the gastroenterologist should know.

F. Guillemin, L. Peyrin-Biroulet, S. Danese, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

P230 Ultrasonography-based and Magnetic Resonance-based Lémann Index: two sides of the same coin

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2022, Journal of Crohn's and Colitis.

IL‐17 Inhibitors and Inflammatory Bowel Diseases: A Postmarketing Study in Vigibase

L. Peyrin-Biroulet, P. Netter, F. D'Amico, 2021, Clinical pharmacology and therapeutics.

Thrombosis in IBD in the era of JAK inhibition.

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2020, Current drug targets.

Fecal calprotectin for the diagnosis of bowel inflammation in patients with rheumatological diseases: a systematic review.

S. Bonovas, D. Loeuille, L. Peyrin-Biroulet, 2019, Journal of Crohn's & colitis.

Vedolizumab and etrolizumab for ulcerative colitis: twins or simple cousins?

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Expert opinion on biological therapy.

IBD goes home: from telemedicine to self-administered advanced therapies

L. Peyrin-Biroulet, S. Danese, V. Solitano, 2021, Expert opinion on biological therapy.

Ustekinumab in Crohn’s Disease: New Data for Positioning in Treatment Algorithm

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2022, Journal of Crohn's & colitis.

Rediscovering histology: what is new in endoscopy for inflammatory bowel disease?

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2021, Therapeutic advances in gastroenterology.

International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients

A. Hart, L. Peyrin-Biroulet, S. Danese, 2023, Medicina.

Emerging drugs for the treatment of moderately to severely active ulcerative colitis: review of phase II and III clinical trials

S. Danese, F. D'Amico, Laura Neurath, 2023, Expert opinion on emerging drugs.

SARS-CoV-2 vaccination in IBD: more pros than cons

L. Peyrin-Biroulet, S. Danese, C. Rabaud, 2021, Nature Reviews Gastroenterology & Hepatology.

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2020, Expert review of clinical immunology.

Nocebo effect and biosimilars in inflammatory bowel diseases: what’s new and what’s next?

L. Peyrin-Biroulet, S. Danese, V. Solitano, 2020, Expert opinion on biological therapy.

Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases

G. Fiorino, S. Danese, M. Allocca, 2022, Journal of clinical medicine.

Identification of the optimal medical and surgical management for patients with perianal fistulising Crohn's disease

C. Brochard, L. Siproudhis, L. Peyrin-Biroulet, 2022, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Promoting psycho-social wellbeing for engaging inflammatory bowel disease patients in their care: an Italian consensus statement

F. Pagnini, S. Danese, A. Armuzzi, 2021, BMC psychology.

Inflammatory Bowel Diseases and COVID-19: The Invisible Enemy

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Gastroenterology.

Inflammatory Bowel Disease Management During the Coronavirus-19 Outbreak: A Survey From the European Crohn’s and Colitis Organization

S. Vavricka, L. Peyrin-Biroulet, S. Danese, 2020, Gastroenterology.

JAK or GUT Selectivity: Tipping the Balance for Efficacy and Safety in Ulcerative Colitis.

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Journal of Crohn's & colitis.

Cluster Randomized Trials: Lessons for Inflammatory Bowel Disease Trials.

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2021, Journal of Crohn's & colitis.

Oral Iron for IBD Patients: Lessons Learned at Time of COVID-19 Pandemic

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Journal of clinical medicine.

Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group.

S. Bonovas, A. Hart, E. Vegni, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Biobetters in patients with immune-mediated inflammatory disorders: An international Delphi consensus.

A. Hart, L. Peyrin-Biroulet, S. Danese, 2021, Autoimmunity reviews.

Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic

G. Fiorino, S. Danese, M. Allocca, 2020, Clinical Gastroenterology and Hepatology.

Risk of Covert Submucosal Cancer in Patients With Granular Mixed Laterally Spreading Tumors.

C. Hassan, R. Maselli, A. Amato, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2022, The New England journal of medicine.

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2021, Gastroenterology.

Systematic Review on Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: It Is Time to Take Stock

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Clinical Gastroenterology and Hepatology.

Artificial Endoscopy and Inflammatory Bowel Disease: Welcome to the Future

G. Fiorino, S. Danese, M. Allocca, 2022, Journal of clinical medicine.

Is selectivity the JAKpot winner for IBD treatment?

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2022, Gastroenterology.

Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2023, Expert opinion on pharmacotherapy.

iSTART-II: An Update on the i Support Therapy–Access to Rapid Treatment (iSTART) Approach for Patient-Centered Therapy in Mild-to-Moderate Ulcerative Colitis

A. Hart, L. Peyrin-Biroulet, S. Danese, 2023, Journal of clinical medicine.

Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study

C. Mussi, G. Sergi, S. Volpato, 2023, European Geriatric Medicine.

Available methods for benefit-risk assessment: lessons for inflammatory bowel disease drugs.

L. Peyrin-Biroulet, S. Danese, V. Jairath, 2022, Journal of Crohn's & colitis.

Risk-Benefit of IBD Drugs: A Physicians and Patients Survey

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2023, Journal of clinical medicine.

Difficult-to-treat inflammatory bowel disease: results from a global IOIBD survey.

D. Rubin, L. Peyrin-Biroulet, I. Dotan, 2022, The lancet. Gastroenterology & hepatology.

Could small molecules be used in combination with biologics for inflammatory bowel disease?

G. Fiorino, S. Danese, F. D'Amico, 2022, Expert review of clinical immunology.

Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo

A. Latiano, O. Palmieri, F. Perri, 2023, Gut.

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Tofacitinib for Acute Severe Colitis: When the going Gets Tough, the Tough Get Going.

L. Peyrin-Biroulet, S. Danese, F. D'Amico, 2020, Journal of Crohn's & colitis.

Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis

L. Peyrin-Biroulet, G. Fiorino, S. Danese, 2023, Journal of clinical medicine.

Impact of the COVID-19 pandemic on work capacities of researchers: An overlooked problem

L. Peyrin-Biroulet, C. Baumann, F. D'Amico, 2021 .

Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?

G. Fiorino, F. D'Amico, A. Zilli, 2022, United European gastroenterology journal.

New Technologies in Digestive Endoscopy for Ulcerative Colitis Patients.

S. Danese, M. Allocca, F. D'Amico, 2023, Biomedicines.

Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting.

C. O'Morain, A. Griffiths, L. Peyrin-Biroulet, 2023, The lancet. Gastroenterology & hepatology.

Incidence of and risk factors for colorectal strictures in ulcerative colitis: a multicenter study.

L. Peyrin-Biroulet, S. Danese, P. Netter, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.